M iniaturization is one way to realize today's demands in the drug discovery process by moving from the standard 96-well plate to higher density microplate formats. In this article we describe the adaptation of a fluorescence-based enzyme assay to the challenges of the 384-and 1536-well plate format. The liquid-handling was realized by the automated micropipettor CyBi-Well™ 96/384/1536* (CyBio AG -formerly JENOPTIK Bioinstruments Gmbh -Jena, Germany). On the basis of optimized liquid-handling parameters pipetting routines were established to perform an enzyme assay (b-galactosidase) in the microplate formats of higher density. Finally, the experimental results were compared to those obtained in the well-established 96-well format.
INTRODUCTION
Today's demands in the drug discovery process force pharmaceutical companies to screen an ever-increasing number of samples (up to 10 6 per compound library), against an also continuously increasing amount of medically important targets. 1 The probability of finding a therapeutically important new lead structure depends on the expressiveness of the screening assays, the quality of the samples (especially their structural diversity) and in a special degree on the number of samples tested. 2, 3 Consequently, miniaturization of established assays has become an advantageous means in high-throughput-screening (HTS), to reduce reagent and sample cost and meet turnaround and space requirements. [4] [5] [6] One way to realize this is to move from the standard 96-well plate to higher density microplate formats. In order to perform the liquid-handling in the 384-and the 1536-well plate formats, the automated micropipettor CyBi-Well™ 96/384/1536 (CyBio AG -formerly JENOPTIK Bioinstruments Gmbh -Jena, Germany) was developed. As appropriate microplate readers are now available, the technical prerequisites for an integration of the 1536-well plate format in the HTSprocess are basically in place. The adaptation of established assay systems to microplate formats of higher density requires a careful examination of the feasibility with special regard to the pipetting error as well as the reproducibility and the sensitivity. Therefore the pipetting routines have been created on the basis of optimization experiments concerning, cross contamination, cleansing of the tips, formation of foam, mixing of different solutions and evaporation, respectively 7 . In this paper we describe the scale down to the 384-and 1536-well plate formats of the b-galactosidase (b-gal) assay using FDG as substrate as a convenient model for a fluorescence-based enzyme assay.
MATERIALS AND METHODS

Instruments
The distribution of the liquids in the microplates was performed with the micropipettor CyBi-Well™ 96/384/1536 (CyBio AG, Jena, Germany). The pipetting module was supported with a double shaft stacker, a tip wash station, a sensor controlled pump for the washing fluid and 3 adapters for plates and reservoirs, respectively. In our experiments a sponge for dabbing off small liquid drops from the top of the tips, a wash station, a reservoir and a microplate adapter have been placed at the track carriage. Pipette tips (polypropylene), with a maximum volume of 250 µl, 25 µl and 10 µl were used to distribute the liquids into microplates 96, 384 and 1536. The pipetting routines have been established using the Opal Control Software version 4.24 for Windows 95ä. The photometric read out of the microplates was carried out with the microplate reader POLARstarä, Version 4.10-0 (BMG LabTechnologies GmbH, Offenburg, Germany). Figure 1 illustrates the layout of the workstation.
Chemicals, biochemicals and materials
All reagents, solvents and media components were used in p.A. 
Enzyme assay
The enzyme b-galactosidase (b-gal) catalyzes the bioconversion of FDG into the fluorescence dye fluorescein in a two step reaction by hydrolyzing the two galactosidic bonds of the substrate. 8, 9 Thus the activity of this well known commercially available enzyme can be quantified by a simple fluorescence read out (l exc = 485 nm and l em = 520 nm). The scheme of this bioconversion is shown in Figure 2 . We used this enzymatic reaction as an example for comparing kinetic studies on the feasibility of enzyme assays in the 96-, 384-and 1536-well microplate plate formats over a time period of 25 minutes without substrate limitation. The fluorescence measurements were performed at 37°C.
The final volume in the different plate formats was decreased in the ratio 1:5 (96-well microplate Þ 150µl per well, 384-well microplate Þ 30µl per well, 1536-well microplate Þ 6µl per well). The enzyme concentration was adjusted in the range from 10 Experiences gained from the optimization experiments were implemented in the development of the different pipetting routines which resulted in a considerable increase in reproducibility of the experiments. 7 The speed of the plate lifter was adjusted in dependence on the pipetted liquid in order to reduce cross-contamination. The occurrence of foam was avoided by reducing the piston speed while dispensing into wells. We integrated resuspension cycles into the protocol which resulted in the formation of optimally mixed solutions, and we developed a sophisticated cleansing procedure that allowed the reuse of the pipette tips. The assay volumes were selected in accordance to the analysis of the evaporation from high density microplate formats. The results of the liquid-handling experiments are described in 7 , in detail. The photometric read out was focused on the detection of the fluorescence intensity. In order to be able to compare the absolute read out data, the sensitivity of the reader had to be adjusted by selecting a suitable 'gain' value.
RESULTS AND DISCUSSION
The kinetics of the bioconversion of FDG is dependent on the enzyme concentration (b-gal) for the three different microplate formats as shown in Figures 3a -3c . The start of the first measurement was determined by the duration of the optimized pipetting protocols for the three microplate formats. In order to get comparable photometric signals the gains were adjusted to 1 (96-well plate), 27 (384-well plate), and 20 (1536-well plate). The distance between the liquid and the detector surface (amount of detected photons), in the 384-well format was larger than in the 1536-and 96-well format which corresponds to the differences in the gain value. The illustrations confirm the remarkable correspondence of the general shape of the graphs. The resulting standard curves have been constructed from the slope of the bioconversion lines in the 96-, 384-, and 1536-well plate formats. The enzymatic substrate bioconversion is a linear function of the time in all three plate types. It displays a linear dependence on the enzyme concentration over the entire period of 25 minutes. The slope of the standard curve decreases slightly from 2.07 x 10 6 in the 96-well plates to 0.96 x 10 6 in the 384-and 0.89 x 10 6 in the 1536-well plates. Mainly physical effects were suggested to be responsible for this behavior. When moving towards higher density microplates, the shape of the wells and the liquid volume changed. This caused an altered surface-to-volume ratio evoking unfavorable wall-effects as well as a modified distance between the liquid surface and the detector surface influencing the photometric signal. The general performance of the assay is not influenced by these effects. In principle, our experiments the enzyme assay was transferable into the 384-and 1536-well microplate formats without any restrictions. As demonstrated in Table 1 , the signal-to-background ratio (S/B = mean signal / mean background), 10 also decreased when lowering the concentration and moving to the higher density plate format. But the S/B ratio still exceeded a value of 36 even though conditions were most unfavorable (1536-well plate format and a -5 units/µl). The standard deviations of the parallel data points and the regression coefficients R of the 3 linear standard curves (Figure 3) indicate the good quality of the assay performance in all three microplate formats.
CONCLUSION
In our in vitro b-galactosidase assay the bioconversion of FDG occurred as a linear function of the enzyme concentration comparably in all three microplate formats. Thus the transferability of this model enzyme assay into the 1536-well plate format was demonstrated. We conclude that miniaturization using the higher density 384-and 1536-well plate formats is advantageous as the next evolutionary step in HTS, especially well suited for in vitro enzyme assays. Consequently, it seems obvious to approach the miniaturization of more complex cellular assays in a similar manner. Yet, for a successful realization of assay systems in those microplate formats, optimized liquid-handling conditions and a careful individual adaptation procedure for each assay are essential. The standard deviations of parallel data points and the regression coefficients of the resulting linear standard curves prove that CyBiWell™ 96/384/1536 is a powerful tool to accurately perform all liquid-handling procedures. Table 1 . Signal-to-Background ratio (S/B) after 25 min is dependent on the b-gal concentration in different microplate formats. 
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